Announcement: IPIC to acquire Nova Chemical-NCX for $6 per share— 02/23/09
Thoughts: Acquisition pricing has never been trickier, such as the price parameters on the Nova deal announced yesterday at 348% premium to market but that represents only 2.6X EBITDA (trailing) and on 0.28X sales. The market values are very depressed in anticipation of an unprecedented business slowdown.
Showing posts with label IPIC/Nova 2-2009. Show all posts
Showing posts with label IPIC/Nova 2-2009. Show all posts
March 4, 2009
Subscribe to:
Posts (Atom)
